1. Home
  2. Drugs
  3. Science and Research | Drugs
  4. Regulatory Science in Action
  5. Impact Stories
  1. Regulatory Science in Action

Impact Stories

To illustrate the unique value of CDER’s regulatory science investments we have developed a series of “impact stories” that describe recent  advances by our researchers and the impacts of these discoveries on drug development and the public health.

Cannabis leaves and Cannabidiol (CBD) chemical structure montage

CDER Investigators Address the Safety of CBD in a Randomized Trial

August 25, 2025

Modern Intact NMR Approach Reveals Synchronized Microstructural Changes in Nanoemulsion Drug Formulations

Modern Intact NMR Approach Reveals Synchronized Microstructural Changes in Nanoemulsion Drug Formulations

August 4, 2025

Streamlining analysis of ion channel in vitro assays data

Streamlining analysis of ion channel in vitro assays data to support clinical cardiac safety decision-making

December 16, 2024

picture for regulatory science impact story raman spectroscopy

Determining topical product bioequivalence with stimulated Raman scattering microscopy

December 14, 2024

Opportunities for innovation in drug development for neurological conditions

Opportunities for innovation in drug development for neurological conditions

July 12, 2024

baolin regulatory science impact story featured image

A novel method for rapid glycan profiling of therapeutic monoclonal antibodies

June 18, 2024

Laptop and two hands with one hand typing and the other holding a stethescope

How physicians interpret information about prescription drugs in scientific publications vs. promotional pieces

April 26, 2024

image of pills and drug bottles

Learning-enabled Natural Language Processing to Identify Directional Pharmacokinetic Drug-Drug Interactions

April 26, 2024

Read our full collection of impact stories on drug development and public health.

Back to Top